Press Esc to close
Saturday 22 July 2017
News updated at 12:03 AM IST

ICMR to test efficacy of two new TB drugs in clinical trials

Kalyan Ray, DH News Service, New Delhi, May 15 2017, 0:32 IST
One of the medicines, Metformin, is widely used to treat type-II diabetes. However, ICMR plans a clinical trial to examine its effectiveness in fighting the TB microbe following encouraging scientific results from Indian biologists. File photo for representation

One of the medicines, Metformin, is widely used to treat type-II diabetes. However, ICMR plans a clinical trial to examine its effectiveness in fighting the TB microbe following encouraging scientific results from Indian biologists. File photo for representation

With India set to witness a steep rise in the number of drug-resistant tuberculosis cases, the Indian Council of Medical Research (ICMR) will test the efficacy of two new medicines for tackling the dreaded bug that causes TB.

One of the medicines, Metformin, is widely used to treat type-II diabetes. However, ICMR plans a clinical trial to examine its effectiveness in fighting the TB microbe following encouraging scientific results from Indian biologists.

The second drug is Bedaquiline that received the US Food and Drug Administration’s approval in 2012 for the treatment of drug-resistant tuberculosis cases. It is yet to be used in India’s public-funded national TB control programme.

“The protocol for the Metformin trial is ready and we hope to start the trial within a couple of months. The Bedaquiline Delaminate (another new drug) trial for drug-resistant cases may take about six months to kick off,” ICMR director general Soumya Swaminathan told DH. The Metformin trial would be held in two steps.

First, there would be a phase-II proof-of-concept trial on a limited number of patients to examine the safety of the drug in TB treatment. It would be followed by a larger trial on the medicine’s efficacy as well as for dose determination.

Go to Top

Photo Gallery
Kawad yatri waiting for their turn in a queue outside a Shiv temple in Meerut...

Kawad yatri waiting for their turn in a queue outside a Shiv temple in Meerut...

A farmer ploughs his paddy field during monsoon session at a village near Balurghat in South...

A farmer ploughs his paddy field during monsoon session at a village near Balurghat in South...

Chennaiyin FC Co-owner and actor Abhishek Bachchan reacts during a press conference...

Chennaiyin FC Co-owner and actor Abhishek Bachchan reacts during a press conference...

Exile Tibetans hold posters of the late Nobel laureate Xiaobo Liu during a prayer service...

Exile Tibetans hold posters of the late Nobel laureate Xiaobo Liu during a prayer service...

Temples submerged in flooded waters of Narmada river at Gwarighat in Jabalpur...

Temples submerged in flooded waters of Narmada river at Gwarighat in Jabalpur...

A view of a submerged bridge over the Panchganga river after heavy downpour at Ichalkaranj...

A view of a submerged bridge over the Panchganga river after heavy downpour at Ichalkaranj...

Former Gujarat chief minister and Congress veteran Shankersinh Vaghela address a public...

Former Gujarat chief minister and Congress veteran Shankersinh Vaghela address a public...

Village girls raise slogan as they attend the funeral procession of the teenager Tanveer...

Village girls raise slogan as they attend the funeral procession of the teenager Tanveer...

Army personnel fixing loud-speakers at a pole as preparations are underway...

Army personnel fixing loud-speakers at a pole as preparations are underway...

A view of the Vijay Chowk and Raisina Hill during sunset in New Delhi on Friday...

A view of the Vijay Chowk and Raisina Hill during sunset in New Delhi on Friday...

Like us on Facebook

Copyright 2017, The Printers (Mysore) Private Ltd., 75, M.G Road, Post Box 5331, Bengaluru - 560001
Tel: +91 (80) 25880000 Fax No. +91 (80) 25880523
Powered by Yodasoft Technologies Pvt. Ltd.